-
Lilly and Merck expand immuno-oncology collaboration
cphi-online
January 13, 2017
Eli Lilly and Merck (MSD) have expanded an existing immuno-oncology collaboration, through a subsidiary, to add a new study of Lilly's Lartruvo (olaratumab) with Keytruda (pembrolizumab) in patients with previously treated advanced or metastatic soft tiss
-
FDA accepts BLA for Mylan and Biocon's proposed biosimilar trastuzumab
cphi-online
January 13, 2017
If approved, MYL-1401O has potential to be the first biosimilar trastuzumab in the US.
-
Philips, Illumina partner to offer integrated genomics solutions for oncology
firstwordpharma
January 11, 2017
Philips and Illumina announced that they will collaborate to leverage Illumina's sequencing technology and BaseSpace Sequence Hub with Philips' cloud-based IntelliSpace Genomics clinical informatics platform in a bid to advance cancer research.
-
Valeant to sell Dendreon cancer business to Sanpower for $820 million
firstwordpharma
January 11, 2017
Valeant Pharmaceuticals announced that it reached an agreement to sell all of its outstanding equity interests in its Dendreon cancer business to Chinese conglomerate Sanpower Group for $820 million in cash.
-
MilliporeSigma Expands Biodevelopment Centers
contractpharma
January 11, 2017
New facilities in NA and China along with full single-use GMP facility in France to accelerate development of biologics
-
SGS Unveils Virus Agent for Clinical Trials
contractpharma
January 11, 2017
Will launch a new strain of influenza virus for use as a challenge agent in clinical trials.
-
Indicia Production Acquires METIS Biotechnologies
contractpharma
January 11, 2017
Flow cytometry technology developed by METIS will complement Indicia's current offering in microbiological analyses
-
Evotec and Eternygen to Develop Metabolic Disease Therapy
contractpharma
January 11, 2017
Evotec AG is extending its existing relationship with Eternygen GmbH by becoming an investor in addition to being a pre-clinical drug discovery partner.
-
Brisk Walk May Help Sidestep Heart Disease
drugs.com
January 11, 2017
Walking at moderate intensity may lower the risk of heart disease, a small study suggests.
-
High Blood Pressure Increasing Worldwide
drugs.com
January 11, 2017
As the number of people around the world with elevated or high blood pressure increases, so do the number of deaths linked to this "silent killer," a new study contends.